Theratechnologies Inc. (TH.TO)
CAD 3.86
(-4.46%)
CAD 3.86
(-4.46%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 72.75 Million USD | -22.34% |
| 2022 | 93.68 Million USD | 30.48% |
| 2021 | 71.79 Million USD | 25.72% |
| 2020 | 57.1 Million USD | 25.09% |
| 2019 | 45.65 Million USD | 32.17% |
| 2018 | 34.54 Million USD | 1.75% |
| 2017 | 33.94 Million USD | 72.28% |
| 2016 | 19.7 Million USD | 20.39% |
| 2015 | 16.36 Million USD | 43.82% |
| 2014 | 11.38 Million USD | 5.66% |
| 2013 | 10.77 Million USD | -15.45% |
| 2012 | 12.73 Million USD | -44.81% |
| 2011 | 23.08 Million USD | -4.87% |
| 2010 | 24.26 Million USD | -26.21% |
| 2009 | 32.88 Million USD | -19.96% |
| 2008 | 41.07 Million USD | 1.07% |
| 2007 | 40.64 Million USD | 68.65% |
| 2006 | 24.09 Million USD | 31.09% |
| 2005 | 18.38 Million USD | -14.46% |
| 2004 | 21.49 Million USD | -13.64% |
| 2003 | 24.88 Million USD | 17.57% |
| 2002 | 21.16 Million USD | 83.89% |
| 2001 | 11.51 Million USD | 61.06% |
| 2000 | 7.14 Million USD | 48.22% |
| 1999 | 4.82 Million USD | 12.21% |
| 1998 | 4.29 Million USD | -8.74% |
| 1997 | 4.7 Million USD | 13.29% |
| 1996 | 4.15 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 14.18 Million USD | 7.37% |
| 2024 Q1 | 13.2 Million USD | -15.95% |
| 2024 Q3 | 11.86 Million USD | -16.33% |
| 2023 FY | 72.75 Million USD | -22.34% |
| 2023 Q4 | 15.71 Million USD | -0.75% |
| 2023 Q2 | 20.58 Million USD | -0.18% |
| 2023 Q1 | 20.62 Million USD | -2.82% |
| 2023 Q3 | 15.83 Million USD | -23.08% |
| 2022 Q4 | 21.22 Million USD | 0.87% |
| 2022 Q3 | 21.03 Million USD | -32.68% |
| 2022 Q2 | 31.25 Million USD | 54.87% |
| 2022 FY | 93.68 Million USD | 30.48% |
| 2022 Q1 | 20.17 Million USD | -1.13% |
| 2021 Q3 | 19.58 Million USD | 13.86% |
| 2021 FY | 71.79 Million USD | 25.72% |
| 2021 Q4 | 20.4 Million USD | 4.2% |
| 2021 Q1 | 14.6 Million USD | -11.93% |
| 2021 Q2 | 17.2 Million USD | 17.8% |
| 2020 Q2 | 14.26 Million USD | 15.54% |
| 2020 Q1 | 12.35 Million USD | -16.6% |
| 2020 FY | 57.1 Million USD | 25.09% |
| 2020 Q4 | 16.58 Million USD | 19.23% |
| 2020 Q3 | 13.9 Million USD | -2.54% |
| 2019 Q4 | 14.8 Million USD | 43.59% |
| 2019 Q2 | 11.04 Million USD | 16.33% |
| 2019 Q1 | 9.49 Million USD | 12.11% |
| 2019 FY | 45.65 Million USD | 32.17% |
| 2019 Q3 | 10.31 Million USD | -6.59% |
| 2018 Q4 | 8.46 Million USD | -4.67% |
| 2018 FY | 34.54 Million USD | 1.75% |
| 2018 Q1 | 8.3 Million USD | -11.47% |
| 2018 Q2 | 9.09 Million USD | 9.58% |
| 2018 Q3 | 8.88 Million USD | -2.37% |
| 2017 Q1 | 5.32 Million USD | 23.85% |
| 2017 FY | 33.94 Million USD | 72.28% |
| 2017 Q4 | 9.37 Million USD | 3.32% |
| 2017 Q3 | 9.07 Million USD | -2.53% |
| 2017 Q2 | 9.31 Million USD | 74.92% |
| 2016 FY | 19.7 Million USD | 20.39% |
| 2016 Q1 | 5.06 Million USD | 7.94% |
| 2016 Q2 | 5.04 Million USD | -0.55% |
| 2016 Q3 | 5.13 Million USD | 1.89% |
| 2016 Q4 | 4.29 Million USD | -16.35% |
| 2015 Q2 | 3.97 Million CAD | 6.77% |
| 2015 Q1 | 3.72 Million USD | 14.6% |
| 2015 Q4 | 4.69 Million USD | 6.12% |
| 2015 FY | 16.36 Million USD | 43.82% |
| 2015 Q3 | 4.42 Million USD | 11.4% |
| 2014 FY | 11.38 Million USD | 5.66% |
| 2014 Q4 | 3.24 Million USD | -3.79% |
| 2014 Q3 | 3.37 Million USD | 139.53% |
| 2014 Q2 | 1.4 Million USD | -56.99% |
| 2014 Q1 | 3.27 Million USD | 26.62% |
| 2013 FY | 10.77 Million USD | -15.45% |
| 2013 Q2 | 2.68 Million USD | 10.6% |
| 2013 Q4 | 2.58 Million USD | -19.26% |
| 2013 Q1 | 2.42 Million USD | -5.96% |
| 2013 Q3 | 3.2 Million USD | 19.4% |
| 2012 Q4 | 2.58 Million USD | -14.91% |
| 2012 FY | 12.73 Million USD | -44.81% |
| 2012 Q3 | 3.03 Million USD | -9.72% |
| 2012 Q2 | 3.35 Million USD | -7.68% |
| 2012 Q1 | 3.63 Million USD | 14.86% |
| 2011 Q3 | 5.59 Million USD | -25.54% |
| 2011 Q2 | 7.5 Million USD | 9.87% |
| 2011 Q1 | 6.83 Million USD | 6.47% |
| 2011 FY | 23.08 Million USD | -4.87% |
| 2011 Q4 | 3.16 Million USD | -43.36% |
| 2010 Q4 | 6.42 Million USD | 28.23% |
| 2010 Q3 | 5 Million USD | -23.46% |
| 2010 Q2 | 6.54 Million USD | 4.78% |
| 2010 Q1 | 6.24 Million USD | -16.4% |
| 2010 FY | 24.26 Million USD | -26.21% |
| 2009 Q3 | 6.68 Million USD | -5.91% |
| 2009 Q2 | 7.1 Million USD | -29.3% |
| 2009 FY | 32.88 Million USD | -19.96% |
| 2009 Q4 | 7.46 Million USD | 11.67% |
| 2009 Q1 | 10.05 Million USD | 31.84% |
| 2008 Q4 | 7.62 Million CAD | -32.12% |
| 2008 Q2 | 12.18 Million CAD | 3.93% |
| 2008 Q1 | 11.72 Million CAD | -7.88% |
| 2008 FY | 41.07 Million USD | 1.07% |
| 2008 Q3 | 11.23 Million CAD | -7.79% |
| 2007 Q4 | 12.72 Million CAD | 23.19% |
| 2007 Q2 | 8.27 Million CAD | -0.38% |
| 2007 FY | 40.64 Million USD | 68.65% |
| 2007 Q1 | 8.3 Million CAD | 42.65% |
| 2007 Q3 | 10.33 Million CAD | 24.8% |
| 2006 Q3 | 6.93 Million CAD | 22.62% |
| 2006 FY | 24.09 Million USD | 31.09% |
| 2006 Q1 | 5.2 Million CAD | -1.3% |
| 2006 Q2 | 5.65 Million CAD | 8.63% |
| 2006 Q4 | 5.82 Million CAD | -15.97% |
| 2005 FY | 18.38 Million USD | -14.46% |
| 2005 Q4 | 5.27 Million CAD | 14.41% |
| 2005 Q3 | 4.6 Million USD | 1.98% |
| 2005 Q2 | 4.51 Million CAD | 19.05% |
| 2005 Q1 | 3.79 Million CAD | -36.53% |
| 2004 FY | 21.49 Million USD | -13.64% |
| 2004 Q4 | 5.98 Million CAD | 61.08% |
| 2004 Q3 | 3.71 Million USD | -38.31% |
| 2004 Q1 | 5.9 Million CAD | -25.74% |
| 2004 Q2 | 6.01 Million CAD | 2.01% |
| 2003 FY | 24.88 Million USD | 17.57% |
| 2003 Q4 | 7.94 Million CAD | 38.52% |
| 2003 Q3 | 5.73 Million CAD | -2.63% |
| 2003 Q2 | 5.89 Million CAD | 17.79% |
| 2003 Q1 | 5 Million CAD | -19.75% |
| 2002 Q1 | 4.88 Million CAD | 43.95% |
| 2002 Q3 | 4.88 Million CAD | -4.49% |
| 2002 Q4 | 6.23 Million CAD | 27.47% |
| 2002 FY | 21.16 Million USD | 83.89% |
| 2002 Q2 | 5.11 Million CAD | 4.81% |
| 2001 FY | 11.51 Million USD | 61.06% |
| 2001 Q4 | 3.39 Million CAD | 4.8% |
| 2001 Q3 | 3.23 Million CAD | 33.56% |
| 2001 Q2 | 2.42 Million CAD | 1.44% |
| 2001 Q1 | 2.38 Million CAD | 16.78% |
| 2000 FY | 7.14 Million USD | 48.22% |
| 2000 Q1 | 1.58 Million CAD | 7.38% |
| 2000 Q2 | 1.86 Million USD | 17.9% |
| 2000 Q3 | 1.53 Million USD | -17.82% |
| 2000 Q4 | 2.04 Million CAD | 33.24% |
| 1999 Q4 | 1.47 Million USD | 16.11% |
| 1999 Q2 | 1.15 Million USD | 24.23% |
| 1999 Q1 | 928.07 Thousand USD | 5.46% |
| 1999 FY | 4.82 Million USD | 12.21% |
| 1999 Q3 | 1.27 Million USD | 10.26% |
| 1998 FY | 4.29 Million USD | -8.74% |
| 1998 Q4 | 880.01 Thousand USD | -26.8% |
| 1998 Q1 | 1.19 Million USD | 23.82% |
| 1998 Q3 | 1.2 Million USD | -7.83% |
| 1998 Q2 | 1.3 Million USD | 9.2% |
| 1997 Q1 | 1.09 Million USD | 0.0% |
| 1997 FY | 4.7 Million USD | 13.29% |
| 1997 Q2 | 1.52 Million USD | 39.02% |
| 1997 Q3 | 1.15 Million USD | -24.4% |
| 1997 Q4 | 964.66 Thousand USD | -16.26% |
| 1996 FY | 4.15 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Aurora Cannabis Inc. | 158.53 Million CAD | 54.108% |
| Avicanna Inc. | 14.59 Million CAD | -398.612% |
| Avant Brands Inc. | 5.65 Million CAD | -1185.669% |
| Cardiol Therapeutics Inc. | 29.53 Million CAD | -146.32% |
| Crescita Therapeutics Inc. | 12.32 Million CAD | -490.552% |
| Knight Therapeutics Inc. | 155.54 Million CAD | 53.224% |
| MediPharm Labs Corp. | 23.08 Million CAD | -215.193% |
| OrganiGram Holdings Inc. | 277.81 Million CAD | 73.811% |
| Canopy Growth Corporation | 308.61 Million CAD | 76.425% |
| Willow Biosciences Inc. | 7.55 Million CAD | -863.145% |
| Auxly Cannabis Group Inc. | 40.28 Million CAD | -80.617% |